Cargando…
Tracing cancer evolution and heterogeneity using Hi-C
Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628133/ https://www.ncbi.nlm.nih.gov/pubmed/37932252 http://dx.doi.org/10.1038/s41467-023-42651-2 |
_version_ | 1785131688743927808 |
---|---|
author | Erdmann-Pham, Dan Daniel Batra, Sanjit Singh Turkalo, Timothy K. Durbin, James Blanchette, Marco Yeh, Iwei Shain, Hunter Bastian, Boris C. Song, Yun S. Rokhsar, Daniel S. Hockemeyer, Dirk |
author_facet | Erdmann-Pham, Dan Daniel Batra, Sanjit Singh Turkalo, Timothy K. Durbin, James Blanchette, Marco Yeh, Iwei Shain, Hunter Bastian, Boris C. Song, Yun S. Rokhsar, Daniel S. Hockemeyer, Dirk |
author_sort | Erdmann-Pham, Dan Daniel |
collection | PubMed |
description | Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture in heterogeneous samples that can infer somatic copy number alterations, characterize large-scale chromosomal rearrangements, and estimate cancer cell fractions. After validating HiDENSEC with in silico and in vitro controls, we used it to characterize chromosome-scale evolution during melanoma progression in formalin-fixed tumor samples from three patients. The resulting comprehensive annotation of the genomic events includes copy number neutral translocations that disrupt tumor suppressor genes such as NF1, whole chromosome arm exchanges that result in loss of CDKN2A, and whole-arm copy-number neutral loss of homozygosity involving PTEN. These findings show that large-scale chromosomal rearrangements occur throughout cancer evolution and that characterizing these events yields insights into drivers of melanoma progression. |
format | Online Article Text |
id | pubmed-10628133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106281332023-11-08 Tracing cancer evolution and heterogeneity using Hi-C Erdmann-Pham, Dan Daniel Batra, Sanjit Singh Turkalo, Timothy K. Durbin, James Blanchette, Marco Yeh, Iwei Shain, Hunter Bastian, Boris C. Song, Yun S. Rokhsar, Daniel S. Hockemeyer, Dirk Nat Commun Article Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture in heterogeneous samples that can infer somatic copy number alterations, characterize large-scale chromosomal rearrangements, and estimate cancer cell fractions. After validating HiDENSEC with in silico and in vitro controls, we used it to characterize chromosome-scale evolution during melanoma progression in formalin-fixed tumor samples from three patients. The resulting comprehensive annotation of the genomic events includes copy number neutral translocations that disrupt tumor suppressor genes such as NF1, whole chromosome arm exchanges that result in loss of CDKN2A, and whole-arm copy-number neutral loss of homozygosity involving PTEN. These findings show that large-scale chromosomal rearrangements occur throughout cancer evolution and that characterizing these events yields insights into drivers of melanoma progression. Nature Publishing Group UK 2023-11-06 /pmc/articles/PMC10628133/ /pubmed/37932252 http://dx.doi.org/10.1038/s41467-023-42651-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Erdmann-Pham, Dan Daniel Batra, Sanjit Singh Turkalo, Timothy K. Durbin, James Blanchette, Marco Yeh, Iwei Shain, Hunter Bastian, Boris C. Song, Yun S. Rokhsar, Daniel S. Hockemeyer, Dirk Tracing cancer evolution and heterogeneity using Hi-C |
title | Tracing cancer evolution and heterogeneity using Hi-C |
title_full | Tracing cancer evolution and heterogeneity using Hi-C |
title_fullStr | Tracing cancer evolution and heterogeneity using Hi-C |
title_full_unstemmed | Tracing cancer evolution and heterogeneity using Hi-C |
title_short | Tracing cancer evolution and heterogeneity using Hi-C |
title_sort | tracing cancer evolution and heterogeneity using hi-c |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628133/ https://www.ncbi.nlm.nih.gov/pubmed/37932252 http://dx.doi.org/10.1038/s41467-023-42651-2 |
work_keys_str_mv | AT erdmannphamdandaniel tracingcancerevolutionandheterogeneityusinghic AT batrasanjitsingh tracingcancerevolutionandheterogeneityusinghic AT turkalotimothyk tracingcancerevolutionandheterogeneityusinghic AT durbinjames tracingcancerevolutionandheterogeneityusinghic AT blanchettemarco tracingcancerevolutionandheterogeneityusinghic AT yehiwei tracingcancerevolutionandheterogeneityusinghic AT shainhunter tracingcancerevolutionandheterogeneityusinghic AT bastianborisc tracingcancerevolutionandheterogeneityusinghic AT songyuns tracingcancerevolutionandheterogeneityusinghic AT rokhsardaniels tracingcancerevolutionandheterogeneityusinghic AT hockemeyerdirk tracingcancerevolutionandheterogeneityusinghic |